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Abstract
Brown adipose tissue and skeletal muscle are known to be important sites for nonshivering thermogenesis. In this context, it is accepted
that uncoupling proteins (UCPs) are involved in such process, but little is known about the physiological regulation of these proteins as
affected by the intake of a high-energy (cafeteria) diet inducing fat deposition. In this study, the UCP messenger RNA (mRNA) expression
in interscapular brown adipose tissue (iBAT) and skeletal muscle was assessed to evaluate the influence of a dietary manipulation on energy
homeostasis regulation. We report a statistically significant increase in mRNA levels of iBAT UCP1 and UCP3 and a statistical marginal
rise in skeletal muscle UCP3 mRNA expression after feeding a high-energy diet, whereas no changes in UCP2 expression were found in
either tissue. Furthermore, significant positive associations between iBAT UCP1 and UCP3 mRNA levels with serum leptin were found.
Although the expression of the b3 adrenoceptor (b3AR) was about 50% in the lean controls compared with the obese group in iBAT, no
statistically significant changes were observed concerning peroxisome proliferator-activated receptor g2 (PPARg2) mRNA levels in muscle
or iBAT. We conclude that feeding a diet inducing weight and fat gain produces different outcomes on iBAT and skeletal muscle UCP
mRNA expression, revealing a tissue-dependent response for the three UCPs. Results suggest that the regulation of UCP expression in both
tissues under these specific dietary conditions may be related to leptin circulating levels. © 2001 Elsevier Science Inc. All rights reserved.
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1. Introduction
Obesity is a disorder of the energy balance in which
energy intake is greater than energy expenditure [1]. The
second factor of the energy equation involves the mainte-
nance of the basal metabolic rate, physical activity, growth
and thermogenesis. In this context, diet-induced thermogen-
esis (DIT) is a metabolic pathway to burn/oxidize the excess
of energy ingested to match energy intake and needs in
order to prevent excessive weight gain [2].
Brown adipose tissue (BAT) is an important site of
facultative (nonshivering) thermogenesis [3], which is
acutely induced by thyroid hormone administration [4],
sympathetic nervous system (SNS) stimulation [5] and cold,
as well as by food intake [6]. Skeletal muscle is another
important site for energy expenditure, but muscle thermo-
genesis seems not to be modulated by the SNS in response
to diet or cold [2], as occurs with BAT. In this sense, the
discovery of new molecular mechanisms underlying ther-
mogenesis such as the uncoupling proteins (UCPs) in the
adipose tissue and skeletal muscle may explain the increas-
ing interest in understanding the role of both tissues in
energy homeostasis.
Mitochondrial UCPs (UCP1, UCP2 and UCP3) appear to
be involved in heat loss by generating a dissipation of the
proton electrochemical gradient across the inner-mitochon-
drial membrane [7]. Brown fat seems to be the only tissue
in which the three UCP genes are coexpressed. UCP2 is
widely distributed in different tissues such as white adipose
tissue (WAT), BAT, skeletal muscle, liver and spleen, and
UCP3 is mainly expressed in skeletal muscle, although it is
also expressed in WAT and BAT [8]. Gene regulation of
these UCPs is quite different and apparently tissue depen-
dent. For instance, the UCP2 and UCP3 mRNA expression
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closely follows that of UCP1 in interscapular brown adipose
tissue (iBAT) because sympathetic stimulation [9], either
induced by b3-agonists [10] or cold [11,12], and thyroid
hormone administration [11] up-regulates the three UCPs.
On the other hand, fasting, free fatty acids, exercise and
thyroid hormone participate in the up-regulation of UCP2
and specially UCP3 in skeletal muscle [13,14]. Neverthe-
less, these UCPs seem not to be affected by cold or sym-
pathetic stimulation in the muscle [2,11,15]. Furthermore,
leptin and glucose have been hypothesized as possible me-
diators of the dietary effects on UCP mRNA expression in
both tissues [16,17].
On the other hand, the b3-adrenergic receptors (b3AR),
which are expressed predominantly in adipocytes, are
known to play a significant role in adipocyte metabolism by
promoting lipolysis and inducing UCP expression. In this
sense, one important physiological regulator of b3AR
mRNA expression in BAT is SNS stimulation. Thus, sym-
pathetic activation by cold exposure dramatically down-
regulates b3AR mRNA expression [18], whereas SNS in-
hibition by surgical denervation up-regulates b3AR mRNA
levels in BAT [18,19]. Thus, this study investigated the
eventual mediation of the adrenergic system after a period
of feeding a high-energy diet in the BAT UCP regulation by
measuring the b3AR mRNA expression levels.
Other potential regulators affecting UCP expression ap-
pear to be the peroxisome proliferator-activated receptors
(PPARs) [3]. These transcription factors belong to a nuclear
receptor superfamily that is involved in the adipocyte dif-
ferentiation process by controlling the expression of several
genes such as UCP mRNA expression [14,20]. In this sense,
some studies have linked UCP mRNA expression with such
receptors in adipose tissues and/or skeletal muscle on dif-
ferent strains of mice or during treatments with PPAR
agonists (thiazolidinediones) [3,21–23]. Nevertheless, little
is known about the regulation of UCP by PPARs, especially
PPARg2, under different nutritional conditions such as
high-energy diet intake.
The main objective of this work was to study the influ-
ence of a dietary manipulation (cafeteria diet intake) in-
creasing fat deposition (overweightness) on UCP mRNA
expression levels in BAT and skeletal muscle. In addition,
plasma glucose, leptin and b3AR gene expression were
assessed. Finally, PPARg was searched as a potential tran-
scription factor involved in the regulation of UCP mRNA
expression after an experimentally induced high-energy
intake.
2. Methods and materials
2.1. Animals and diets
Female Wistar rats, supplied by the Applied Pharmaco-
biology Center (CIFA-Spain), weighing about 150 g, were
housed at 22 6 1°C with a 12-hour light cycle (8:00 AM to
8:00 PM) and assigned to two dietary categories. One group
of animals was fed on a standard diet (Rodent Toxicologic
Diet, B&K Universal) containing 160 g of protein, 710 g of
carbohydrates and 30 g of lipid per kg of diet (15,204 kj/kg)
for 8 days (control group, n 5 8). To obtain a diet-induced
obesity model, another group was fed a fat-rich high-energy
diet (cafeteria diet), whose components were pate´, bacon,
chips, cookies, chocolate and chow with proportions 2:1:1:
1:1:1. This experimental diet is nutritionally balanced and
was offered to induce overweightness, which is widely
accepted despite the differences in the nutrient content [13,
24,25]. The macronutrient composition of the cafeteria diet
was 103 g of protein, 357 g of carbohydrates and 330 g of
lipids, which provided 19,614 kjoules per kg of diet. This
group was offered this diet for 8 days (high-energy diet, n 5
8). All animals had ad libitum access to water and food
during the experimental trial. After 8 days of feeding, ani-
mals were fasted for 12 h, killed by decapitation and the
trunk blood was collected. iBAT and skeletal muscle from
the leg (gastrocnemius muscle) were immediately excised,
weighed, frozen in liquid nitrogen and stored at 280°C until
analysis. All experimental procedures were performed ac-
cording to national and institutional guidelines for animal
care and use at the University of Navarra, Pamplona, Na-
varra, Spain.
2.2. Serum measurements
Serum leptin was determined with a correlate-EIA kit
(rat leptin Enzyme Immunometric Assay Kit, Assay De-
signs, Inc.) following standard procedures. Free fatty acids
were measured by the NEFA C ACS-ACOD method (Waco
Chemicals USA, Inc., Richmond, VA, USA). Glycerol and
triacylglycerol were determined with the RANDOX kit for
glycerol and triacylglycerol diagnostic, respectively (Ran-
dox Laboratories LTD, Ardmore Road, UK) and glucose
was measured with the commercial kit Unimate 7 PAP
(Roche, Basilea, Switzerland). The glycerol, triacylglycerol,
glucose and fatty acid kits were adapted for COBAS MIRA
(Roche, Basilea, Switzerland) equipment.
2.3. Extraction of total RNA and semiquantitation by
reverse transcription-polymerase chain reaction
(RT-PCR)
Total RNA was isolated by the Ultraspec-II RNA Isola-
tion System (Biotecx Laboratories, Houston, TX, USA)
from 100 mg of brown fat and skeletal muscle. After 30-min
treatment with 10 units of RNase-free DNase I (Boehringer
Mannheim, Barcelona, Spain), 1.5 mg of RNA were used to
synthesize first-strand complementary DNA (cDNA). The
RT reaction was carried out in a volume of 30 ml containing
50 mM Tris HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10
mM dithiothreitol, 100 ng of random hexamers (Boehringer
Mannheim), 1 mM each DTP (Bioline, London, UK), 20
units of RNase inhibitor (Promega, Madison, USA), 200
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units of M-MLV RT (Gibco BRL, Life Technologies,
Gaithersburg, MD, USA) and incubated at 37°C for 60 min.
The enzyme was inactivated by heating at 95°C for 5 min.
Four ml from the RT reaction were amplified in a 50-ml
reaction mixture containing 40 ng of each primer, 16 mM
(NH4)2SO4, 67 mM Tris HCl (pH 8.8), 2 mM MgCl2, 0.1%
Tween-20, 0.2 mM each dNTP and 1 unit of BioTaq poly-
merase (Bioline). Primers used to amplify UCP1 cDNA
(GenBank M11814) were 59-GTCTTAGGGACCATCACCA-39
(sense, 351–369) and 59-CCAGTGTAGCGGGGTTT-39 (anti-
sense, 629–646); UCP2 (GenBank AF039033) 59-TAAAG
CAGTTCTACACCAAGGG-39 (sense, 308–329) and 59-CGA
AGGCAGAAGTGAAGTGG-39 (antisense, 648–667); UCP3
(GenBank U92069) 59-GGAACTGGAGGCGAGAGGAA-39
(sense, 577–596) and 59-TTTGTAGAAGGC-TGTGGGGC-39
(antisense, 926–945); PPARg2 (GenBank Y12882) 59-TCT
GATTA-TGGGTGAAACT-C-39 (sense 43–62) and 59-TTTC
TACTCTTTTTGTGGATC-39 (antisense 592–612); b3AR
(GenBank S56481) 59-CTTCTACCTTCCCCTCCTT-39 (sense,
638–656) and 59-CTTCATAGCCATCAAAC-CTG-39 (anti-
sense, 1172–1191); b-actin (GenBank J00691) 59-TCTACAAT
GAGCTGCGGTG-39 (sense 1599–1618) and 59-GGTCAG
GATCTTCATGAGGT-39 (antisense, 2357–2376). Primers for
all genes were designed using the Oligo 4.05 Primer Analysis
Software (National Bioscience, Inc., Plymouth, MN, USA).
cDNA was amplified using the parameters shown in Table 1.
A first step of denaturation was applied (95° for 30 s) and
a final extension step for all primers at 72°C for 7 min in all
cases. To ensure the linearity of PCR reactions and to
validate the cDNA quantitation, adequate controls and stan-
dard curves were carried out by amplifications of 200 ng of
first strand cDNA per reaction from 20 to 40 cycles, as
previously reported [25]. Amplifications were linear under
the conditions shown in Table 1 and were carried out in a
GeneAmp PCR System 2400 (Perkin Elmer, Norwalk, CT,
USA). The amplified products were resolved in a 1.5%
agarose gel with ethidium bromide. Levels of mRNA were
measured as the ratio of signal intensity for each gene
relative to b-actin. PCR band intensities were determined
by densitometric analysis with the Gel Doc 1000 ultraviolet
fluorescent gel documentation system and Molecular Ana-
lyst 1.4.1 software for quantitation of images (Bio-Rad,
Hercules, CA, USA). Furthermore, data obtained concern-
ing UCP, PPARg2 and b3AR mRNA were comparable to
values in the literature using RT-PCR and other methods
(Northern blot) under different experimental treatments.
2.4. Statistical analysis
All results are expressed as means 6 standard error of
the mean (S.E.M.). Data were analyzed using the two-tailed
unpaired t test or U Mann-Whitney in case of a nonpara-
metric distribution. The Pearson correlation coefficient was
computed to analyze correlations between two variables.
The calculations were performed using the SPSS/Windows
version 6.1.3 (SPSS Inc., Chicago, IL, USA) statistical




Overweight was induced in rats by offering a palatable
high-energy diet (Table 2). Outcome of feeding the high-
energy diet was confirmed by the significant increase
(P , .01) in body weight exhibited by the group of rats fed
the high-energy diet with respect to the control group. Also,
BAT weight was significantly higher in obese animals than
in control rats (50% increase, P , .01), whereas no
Table 1
Weight-related measurements and serum determinations in control and high-energy-fed rats
BAT Muscle
Annealing Elongation No. cycles Annealing Elongation No. cycles
UCP1 58°300 72°300 21
UCP2 61°300 72°300 30 61°300 72°300 30
UCP3 61°300 72°300 33 63°300 72°300 33
PPARg2 52°300 72°400 45 53°450 72°500 47
b-actin 59°300 72°300 27 59°300 72°300 27
b3AR 58°300 72°300 30
Table 2
Weight-related measurements and serum determinations in control and
high-energy-fed rats
Control High-energy
Weight increase (g) 24.4 6 2.4 44.8 6 4.6**
BAT weight (g) 0.1 6 0.01 0.2 6 0.02**
Muscle weight (g) 1.2 6 0.05 1.2 6 0.05
Serum glucose (mg/dl) 78 6 4.3 95 6 3.4*
Leptin (ng/ml) 29 6 8.6 56 6 7.2**
Fatty acids (meq/l) 1.3 6 0.04 0.9 6 0.05
Triacilglycerol (mg/dl) 112 6 8.7 59 6 7.8**
Glycerol (mmol/l) 362 6 37.7 270 6 30.3*
Data are means 6 S.E.M. (n 5 8 in all cases). All comparisons were
performed by two-tailed unpaired t tests. Asterisks denote statistically
significant differences (* P , .05, ** P , .01) between both experi-
mental groups.
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changes were observed in gastrocnemius muscle weights
after the experimental feeding period.
3.2. Effects of high-energy intake on serum markers
Serum fatty acids were slightly, but not statistically,
modified after the high-energy diet, whereas serum glucose
was significantly (P , .05) increased in the obese. Fur-
thermore, serum triacylglycerol and glycerol levels were
significantly decreased (P , .01 and P , .05, respec-
tively) in the obese group compared with control animals.
On the other hand, serum leptin levels were significantly
higher (P , .01) in the obese group than in the lean group.
3.3. Brown adipose mRNA levels and statistical
associations with other determinations
UCP mRNA levels in BAT were differently affected by
the intake of a high-energy diet (Fig. 1). Thus, UCP1
mRNA levels were significantly increased (P , .05) in the
group fed the high-energy diet compared with the control
group, as well as UCP3 mRNA levels (P , .05), whereas
no changes were observed in UCP2 mRNA. The b3AR
mRNA expression levels were significantly increased (P ,
.05) in the group of animals eating the high-energy diet
compared with the control group (Fig. 2a). On the other
hand, the high-energy diet seemed to produce no effects on
PPARg2 mRNA expression levels in this tissue (Fig. 2b).
Statistically significant associations were achieved between
serum leptin with UCP1 (r 5 .665, P , .01) and UCP3
(r 5 .496, P , .05) in BAT (Fig. 4a and 4b, respectively).
3.4. Skeletal muscle mRNA levels and statistical
associations with other variables
The possible effects of high-energy diet on the expres-
sion of some skeletal muscle genes such as PPARg2, UCP2
and especially UCP3 were assessed (Fig. 3a and 3b). Op-
posite to BAT, no statistically significant differences de-
pending on dietary patterns on PPARg2, UCP2 and UCP3
mRNA expression levels were detected. Nevertheless,
UCP3 mRNA levels were marginally increased (P , .06,
one-tail Student’s t test) in the obese group when compared
with controls (Fig. 3a). Furthermore, PPARg2 mRNA anal-
Fig. 1. UCP1, UCP2, UCP3 mRNA levels in iBAT in control and high-energy-fed rats. Data are means 6 S.E.M. of the ratio between each gene and b-actin.
Expression of each gene was related to the respective control. An asterisk indicates significant differences (*P , .05) between control and high-fat diet in
each experimental group.
Fig. 2. (a) iBAT b3AR mRNA levels and (b) PPARg2 mRNA levels in control and high-energy fed rats. Data are means 6 S.E.M. of the ratio between each
gene and b-actin. Expression of each gene was related to the respective control. An asterisk indicates significant differences (*P , .05) between control
and high-fat diet in each experimental group.
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ysis showed no statistically significant differences after the
period feeding the high-energy diet (Fig. 3b). When asso-
ciations were analyzed in this tissue, a positive statistically
significant relationship was obtained between muscle UCP3
and serum glucose (r 5 .613, P , .05), whereas a
negative correlation for muscle UCP3 with PPARg2 mRNA
levels (r 5 2.728; P , .01) was found (Fig. 4c and 4d,
respectively).
4. Discussion
High-energy diets are widely used and accepted in nu-
tritional experiments as a good strategy to induce over-
weightness and fat deposition in animals [25,26]. Thus, the
assayed period of high-energy feeding induced a marked
weight increase in rats. The low levels of circulating fatty
acid and other lipid metabolism markers may be due to a
physiological response in order to store the fatty acid (en-
ergy) excess when animals are fed ad libitum on this ex-
perimental diet. Furthermore, this model of diet-induced
obesity has been demonstrated to affect oxygen consump-
tion in different tissues and the respiratory quotient [24].
In this context, despite the known specific effects of
long-chain fatty acids on fatty acid oxidation and mitochon-
drial oxidative phosphorylation [27,28], it is well docu-
mented that high-energy diets may produce gene expression
and composition changes in BAT [1,29]. Thus, in this di-
etary trial, high-energy diet intake significantly increased
iBAT UCP1 and UCP3 mRNA levels as previously reported
[11,30], which suggests that mechanisms controlling UCP1
and UCP3 expression may be similar. Also, several studies
carried out to clarify UCP regulation under different exper-
imental circumstances revealed that b3-adrenergic agonists
[10,31], leptin infusion [32,33], thyroid hormone adminis-
tration [4,11] and cold exposure [11,32] induced a signifi-
cant increase in UCP1 and UCP3 mRNA levels. The results
of these studies suggested that the gene expression of both
UCPs were similarly modified by those factors that occur
after feeding a high-energy diet. In this context, it has been
shown that UCP2 mRNA levels were increased after b3-
agonist treatment [10] and cold exposure [12,34]. However,
in contrast to UCP1 and UCP3, the expression levels of
UCP2 in iBAT were not modified after feeding a high-
energy diet. As a whole, these data reveal that the mecha-
nisms controlling UCP1 and UCP3, but not those of UCP2,
may be influenced by high-energy-yielding diets, thus pro-
moting DIT after high-energy feeding, which suggest that at
least in iBAT, different mechanisms may be involved con-
cerning UCP regulation.
The sympathetic stimulation through b3AR is one of the
most important mechanisms regulating iBAT UCPs [9].
Thus, b3AR are involved in energy expenditure regulation
by triggering lipolysis in BAT and WAT and thermogenesis
in BAT [10,35]. In this sense, it has been reported that
b3AR mRNA in iBAT is negatively correlated with the SNS
activity. Thus, high b3AR mRNA levels are observed under
low SNS activity [35,36], whereas stimulation of the SNS
down-regulates b3AR mRNA levels [19]. Our results sug-
gest that other additional mechanisms apart from adrenergic
stimulation should be involved in the up-regulation of
UCP1 and UCP3, as already published [16], because the
high b3AR mRNA levels may indicate that a high-energy
diet intake can decrease the SNS activation [35]. Other
possible mechanisms that could be involved in iBAT UCP
regulation in response to dietary manipulations may include
the nuclear receptor PPARg and the adipocyte hormone
leptin [16,37].
The assessment of PPARg2 mRNA expression in BAT
as a possible molecular mediator in the up-regulation of
both UCPs (UCP1 and UCP3) produced no significant dif-
ferences between both groups. Although an overexpression
of these nuclear receptors has been reported to induce UCP
expression in BAT [3,37], high-energy feeding apparently
did not promote such PPARg2 overexpression and, there-
fore, no role for such a transcriptional factor in mediating
thermogenesis in iBAT after high-energy feeding could be
ascribed.
Another potential factor implicated in the regulation of
UCP in iBAT is serum leptin, which is known to play a
major role in energy homeostasis [38]. Increasing fat stores
induced by high-energy diet intake produce an elevation of
serum leptin levels, which suppresses food intake and in-
creases energy dissipation, probably by promoting UCP
Fig. 3. (a) Skeletal muscle UCP2 and UCP3 mRNA levels and (b) PPARg2 mRNA levels in control and high-energy fed rats. Data are means 6 S.E.M. of
the ratio between each gene and b-actin. Expression of each gene was related to the respective control. A plus indicates P 5.06.
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expression in iBAT, as previously reported [16,32,33]. This
is in good agreement with the statistically significant rela-
tionships obtained between both iBAT UCPs (UCP1 and
UCP3) with serum leptin.
On the other hand, skeletal muscle is another tissue
involved on energy dissipation (thermogenesis) via UCPs
[39,40]. Thus, the occurrence of a tissue-dependent regula-
tion of these mitochondrial proteins has been reported under
different dietary, pharmacological and physiological cir-
cumstances [2,11,12,40]. A marginal increase (P , .06) in
muscle UCP3 mRNA levels was found in the high-energy-
fed group, whereas no changes were observed for skeletal
muscle UCP2 mRNA levels. A number of studies have been
carried out under different situations showing that both
muscle UCPs are similarly regulated, but UCP3 seemed to
be much more sensitive to changes. Thus, leptin [40], fast-
ing [2] and exercise [41] increase expression of both pro-
teins, whereas refeeding after fasting [2] and b3 adrenergic
agonist administration [10] decrease their levels. Our results
showed a significant increase in mRNA UCP3 levels in
animals fed a high-calorie diet, and are in accordance with
previous data [7,15]. Also, muscle UCP3 mRNA levels
were statistically associated with serum glucose levels, as
has been reported in a previous study with hyperglycemic
mice [23]; this supports the possibility that muscle UCP3
function may be related to glucose metabolism and insulin
resistance [42], probably through the glucose transporter
GLUT4 [17].
Because no dietary effects were observed on muscle
UCP2 mRNA expression levels, it can be suggested that
muscle UCP2 is apparently not sensitive to nutritional
changes as occurs for WAT UCP2, confirming different
regulatory mechanisms concerning UCPs. On the other
hand, a number of studies have focused on assessing a
potential regulatory role for PPARg2 in the muscle UCP
mRNA expression in rats, but there are no clear conclusions
because controversial results have been reported [3,21,23,
39]. In this sense, our results showed that high-energy diet
intake lowered muscle PPARg2 mRNA levels, but not in a
statistically significant manner. Nevertheless, a significant
negative relation was found between PPARg2 expression
with muscle UCP3 (Fig. 4d), suggesting that muscle UCP3
mRNA expression may be negatively affected by PPARg2
under fat-feeding conditions, as previously reported after
the administration of a PPAR agonist [23].
In summary, this study provided information about the
Fig. 4. Associations between (a) iBAT UCP1 mRNA levels with serum leptin; (b) iBAT UCP3 mRNA levels with serum leptin; (c) muscle UCP3 mRNA
levels with serum glucose; (d) UCP3 mRNA levels with PPARg2 mRNA levels in skeletal muscle. Asterisks indicates significant association (*P , .05 and
**P , .01) between variables.
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differential physiological changes of some genes related to
thermogenesis after a period of high-energy feeding, pro-
ducing an increase weight gain in a nongenetically obese
animal strain. Results show that UCPs may follow different
tissue-dependent regulatory mechanisms that may be linked
to leptin circulating levels. Thus, BAT UCP1 and UCP3
seem to respond in the same way to a high-energy diet,
whereas expression patterns exhibited by UCP3 in skeletal
muscle under the same conditions are more difficult to
explain than in iBAT. This experiment suggests that skeletal
muscle gene expression is less sensitive to nutritional
changes than iBAT.
Acknowledgments
The financial support of PIUNA and LE 97 is credited.
The technical assistance of Vero´nica Ciaurriz is gratefully
acknowledged.
References
[1] R.S. Surwit, S. Wang, A.E. Petro, D. Sanchis, S. Raimbault, D.
Ricquier, S. Collins, Diet-induced changes in uncoupling proteins in
obesity-prone and obesity-resistant strains of mice, Proc. Natl. Acad.
Sci. USA 95 (1998) 4061–4065.
[2] S. Samec, J. Seydoux, A.G. Dulloo, Role of UCP homologues in
skeletal muscles and brown adipose tissue: mediators of thermogen-
esis or regulators of lipids as fuel substrate, FASEB J. 12 (1998)
715–724.
[3] L.J. Kelly, P.P. Vicario, G.M. Thompson, M.R. Candelore, T.W.
Doebber, J. Ventre, M.S. Wu, R. Meurer, M.J. Forrest, M.W. Conner,
M.A. Cascieri, D.E. Moller, Peroxisome proliferator-activated recep-
tors gamma and alpha mediate in vivo regulation of uncoupling
protein (UCP-1, UCP-2, UCP-3) gene expression, Endocrinology 139
(1998) 4920–4927.
[4] M.L. Reitman, Y. He, D.W. Gong, Thyroid hormone and other
regulators of uncoupling proteins, Int. J. Obes. Relat. Metab. Disord.
23 (1999) S56–S59.
[5] L. Landsberg, M.E. Saville, J.B. Young, Sympathoadrenal system
and regulation of thermogenesis, Am. J. Physiol. 247 (1984) E181–
E189.
[6] B.E. Levin, A.C. Sullivan, Regulation of thermogenesis in obesity,
Int. J. Obes. Relat. Metab. Disord. 8 (1984) 159–180.
[7] J. Matsuda, K. Hosoda, H. Itoh, C. Son, K. Doi, T. Tanaka, Y.
Fukunaga, G. Inoue, H. Nishimura, Y. Yoshimasa, Y. Yamori, K.
Nakao, Cloning of rat uncoupling protein-3 and uncoupling protein-2
cDNAs: their gene expression in rats fed high-fat diet, FEBS Lett.
418 (1997) 200–204.
[8] P. Schrauwen, K. Walder, E. Ravussin, Human uncoupling proteins
and obesity, Obes. Res. 7 (1999) 97–105.
[9] D. Ricquier, F. Bouillaud, The mitochondrial uncoupling protein:
Structural and genetic studies, Prog. Nucl. Acid Res. Mol. Biol. 56
(1997) 83–108.
[10] H. Yoshitomi, K. Yamazaki, S. Abe, I. Tanaka, Differential regula-
tion of mouse uncoupling proteins among brown adipose tissue, white
adipose tissue, and skeletal muscle in chronic beta 3 adrenergic
receptor agonist treatment, Biochem. Biophys. Res. Commun. 253
(1998) 85–91.
[11] S. Larkin, E. Mull, W. Miao, R. Pittner, K. Albrandt, C. Moore, A.
Young, M. Denaro, K. Beaumont, Regulation of the third member of
the uncoupling protein family, UCP3, by cold and thyroid hormone,
Biochem. Biophys. Res. Commun. 240 (1997) 222–227.
[12] O. Boss, S. Samec, A. Dulloo, J. Seydoux, P. Muzzin, J.P. Giacobino,
Tissue-dependent upregulation of rat uncoupling protein-2 expression
in response to fasting or cold, FEBS Lett. 412 (1997) 111–114.
[13] M.S. Corbala´n, J. Margareto, J.A. Martı´nez, A. Marti, High-fat feed-
ing reduced muscle uncoupling protein 3 expression in rats,
J. Physiol. Biochem. 55 (1999) 67–72.
[14] I. Nagase, S. Yoshida, X. Canas, Y. Irie, K. Kimura, T. Yoshida, M.
Saito, Up-regulation of uncoupling protein 3 by thyroid hormone,
peroxisome proliferator-activated receptor ligands and 9-cis retinoic
acid in L6 myotubes, FEBS Lett. 461 (1999) 319–322.
[15] D.W. Gong, Y. He, M.L. Reitman, Genomic organization and regu-
lation by dietary fat of the uncoupling protein 3 and 2 genes, Bio-
chem. Biophys. Res. Commun. 256 (1999) 27–32.
[16] P.J. Scarpace, M. Matheny, R.L. Moore, M.V. Kumar, Modulation of
uncoupling protein 2 and uncoupling protein 3: Regulation by dener-
vation, leptin and retinoic acid treatment, J. Endocrinol. 164 (2000)
331–337.
[17] N. Tsuboyama Kasaoka, N. Tsunoda, K. Maruyama, M. Takahashi,
H. Kim, D.W. Cooke, M.D. Lane, O. Ezaki, Overexpression of
GLUT4 in mice causes up-regulation of UCP3 mRNA in skeletal
muscle, Biochem. Biophys. Res. Commun. 258 (1999) 187–193.
[18] J.G. Granneman, K.N. Lahners, Differential adrenergic regulation of
b1- and b3-adrenceptor messenger ribonucleic acids in adipose tis-
sues, Endocrinology 130 (1992) 109–114.
[19] T. Onai, G. Kilroy, D.A. York, G.A. Bray, Regulation of beta 3-ad-
renergic receptor mRNA by sympathetic nerves and glucocorticoids
in BAT of Zucker obese rats, Am. J. Physiol. 269 (1995) R519–R526.
[20] J. Aubert, O. Champigny, P. Saint Marc, R. Negrel, S. Collins, D.
Ricquier, G. Ailhaud, Up-regulation of UCP-2 gene expression by
PPAR agonists in preadipose and adipose cells, Biochem. Biophys.
Res. Commun. 238 (1997) 606–611.
[21] A. Acı´n, M. Rodrı´guez, H. Rique, E. Canet, J.A. Boutin, J.P. Galizzi,
Clonning and characterization of the human uncoupling protein 3
(UCP3) gene, Biochem. Biophys. Res. Commun. 258 (1999) 278–283.
[22] I.B. Sears, M.A. MacGinnitie, L.G. Kovacs, R.A. Graves, Differen-
tiation-dependent expression of the brown adipocyte uncoupling pro-
tein gene: regulation by peroxisome proliferator-activated receptor
gamma, Mol. Cell. Biol. 16 (1996) 3410–3419.
[23] T. Shimokawa, M. Kato, Y. Watanabe, R. Hirayama, E. Kurosaki, H.
Shikama, S. Hashimoto, In vivo effects of pioglitazone on uncoupling
protein-2 and -3 mRNA levels in skeletal muscle of hyperglycemic
KK mice, Biochem. Biophys. Res. Commun. 251 (1998) 374–378.
[24] B. Berraondo, A. Bonafonte, M.P. Ferna´ndez-Otero, J.A. Martı´nez,
Effects on energy utilization of a beta-3 adrenergic agonist in rats fed
on a cafeteria diet, Eating Weight Disord. 2 (1997) 130–137.
[25] B. Berraondo, A. Marti, J.S. Duncan, P. Trayhurn, J.A. Martı´nez,
Up-regulation of the muscle UCP2 gene expression by a new beta
3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but
down-regulation in lean animals, Int. J. Obes. 24 (2000) 156–163.
[26] B.E. Levin, J. Triscari, S. Hogan, A.C. Sullivan, Resistance to diet-
induced obesity: food intake, pancreatic sympathetic tone, and insu-
lin, Am. J. Physiol. 252 (1987) R471–R478.
[27] J.A. Ontko, M.L. Johns, Evaluation of malonyl-CoA in the regulation
of long-chain fatty acid oxidation in the liver. Evidence for an un-
identified regulatory component of the system, Biochem. J. 192
(1980) 959–962.
[28] G.A. Cook, D.A. Otto, M.W. Cornell, Differential inhibition of ke-
togenesis by malonyl-CoA in mitochondria from fed and starved rats,
Biochem. J. 192 (1983) 955–958.
[29] D.V. Muralidhara, M. Desautels, Changes in brown adipose tissue
composition during fasting and refeeding of diet-induced obese mice,
Am. J. Physiol. 266 (1994) R1907–R1915.
[30] H. Oudart, R. Groscolas, C. Calgari, M. Nibbelink, C. Leray, Y. Le
Maho, A. Malan, Brown fat thermognesis in rats fed high-fat diets
136 J. Margareto et al. / Journal of Nutritional Biochemistry 12 (2001) 130–137
enriched with n-3 polyunsaturated fatty acids, Int. J. Obes. Relat.
Metab. Disord. 21 (1997) 955–962.
[31] E. Savontaus, J. Rouru, O. Boss, R. Huupponen, M. Koulu, Differ-
ential regulation of uncoupling proteins by chronic treatments with
beta 3-adrenergic agonist BRL 35135 and metformin in obese fa/fa
Zucker rats, Biochem. Biophys. Res. Commun. 246 (1998) 899–904.
[32] O. Boss, T. Hagen, B.B. Lowell, Uncoupling proteins 2 and 3,
Diabetes 49 (2000) 143–156.
[33] P.J. Scarpace, M. Nicolson, M. Matheny, UCP2, UCP3 and leptin
gene expression: modulation by food restriction and leptin, J. Endo-
crinol. 159 (1998) 349–357.
[34] M.C. Carmona, A. Valmaseda, S. Brun, O. Vinas, T. Mampel, R.
Iglesias, M. Giralt, F. Villarroya, Differential regulation of uncou-
pling protein-2 and uncoupling protein-3 gene expression in brown
adipose tissue during development and cold exposure, Biochem.
Biophys. Res. Commun. 243 (1998) 224–228.
[35] S. Collins, K. Daniel, E. Rohlfs, Depressed expression of adipocyte
beta-adrenergic receptors is a common feature of congenital and
diet-induced obesity in rodents, Int. J. Obes. Relat. Metab. Disord. 23
(1999) 669–677.
[36] S. Collins, K.W. Daniel, A.E. Petro, R.S. Surwit, Strain-specific
response to beta 3-adrenergic receptor agonist treatment of diet-
induced obesity in mice, Endocrinology 138 (1997) 405–413.
[37] H.M. Guardiola Diaz, S. Rehnmark, N. Usuda, T. Albrektsen, D.
Feltkamp, J.A. Gustafsson, S.E. Alexson, Rat peroxisome prolifera-
tor-activated receptors and brown adipose tissue function during cold
acclimatization, J. Biol. Chem. 274 (1999) 23368–23377.
[38] J.A. Martinez, G. Fruhbeck, Regulation of energy balance and adi-
posity: a model with new approaches, Rev. Esp. Fisiol. 52 (1996)
255–258.
[39] S. Brun, M.C. Carmona, T. Mampel, O. Vin˜as, M. Giralt, R. Iglesias,
F. Villarroya, Activators of peroxisome proliferator-activated recep-
tor-a induce the expression of the uncoupling protein-3 gene in
skeletal muscle, Diabetes 48 (1999) 1217–1222.
[40] J. Gomez Ambrosi, G. Fruhbeck, J.A. Martinez, Leptin, but not a beta
3-adrenergic agonist, upregulates muscle uncoupling protein-3 mes-
senger RNA expression: short-term thermogenic interactions, Cell.
Mol. Life. Sci. 55 (1999) 992–997.
[41] R.N. Cortright, D. Zheng, J.P. Jones, J.D. Fluckey, S.E. DiCarlo, D.
Grujic, B.B. Lowell, G.L. Dohm, Regulation of skeletal muscle
UCP-2 and UCP-3 gene expression by exercise and denervation,
Am. J. Physiol. 276 (1999) E217–E221.
[42] S. Samec, J. Seydoux, A.G. Dulloo, Post-starvation gene expression
of skeletal muscle uncoupling protein 2 and uncoupling protein 3 in
response to dietary fat levels and fatty acid composition: a link with
insulin resistance, Diabetes 48 (1999) 436–441.
137J. Margareto et al. / Journal of Nutritional Biochemistry 12 (2001) 130–137
